Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphoma
British Journal of Dermatology · 23.01.2023 · 188 (1) · 145-146
DOI: 10.1093/bjd/ljac012 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 20.10.2022. Verfasst von Mathias Oymanns und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venerology, Helios Klinikum Krefeld, Krefeld, Germany. Hauptthemen laut MEDLINE: Immunoconjugates, Lymphoma, T-Cell, Cutaneous, Skin Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Patients with advanced stage mycosis fungoides (MF) or Sézary syndrome (SS) have a poor prognosis. Despite many available active single agents for CTCL treatment, high remission rates and long-lasting responses are rarely achieved in advanced CTCL [1]. Therefore, it is important to find more effective strategies, e.g. combination therapy, which could enhance efficacy by targeting key pathways in a synergistic or additive manner. We report on three patients with tumor stage MF (IIB) with fast response and very good partial remission due to induction with BV with 1.8 mg/kg dose concurrently in combination with ultra-hypofractionated low dose TSEBT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venerology, Helios Klinikum Krefeld, Krefeld, Germany.
- Department of Radiotherapy and Radiooncology, Helios Klinikum Krefeld, Krefeld, Germany.
- Department of Pediatrics, HELIOS Klinikum Krefeld, Krefeld, Germany.
- Department of Radiation Therapy and Radio-Oncology, University Hospital Münster, Münster, Germany.
- Institute for Molecular Medicine, Medical School Hamburg, Hamburg, Germany.
ORCID-Profile: Mathias Oymanns
Zitieren
APA
Oymanns, M., Daum-Marzian, M., Bellm, A., Elsayad, K., Eich, H. T., & Assaf, C. (2023). Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphoma. British Journal of Dermatology, 188(1), 145-146. https://doi.org/10.1093/bjd/ljac012
Vancouver
Oymanns M, Daum-Marzian M, Bellm A, Elsayad K, Eich HT, Assaf C. Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphoma. British Journal of Dermatology. 2023;188(1):145-146. doi:10.1093/bjd/ljac012
BibTeX
@article{Oymanns2023,
author = {Oymanns, Mathias and Daum-Marzian, Michael and Bellm, Aliyah and Elsayad, Khaled and Eich, Hans T and Assaf, Chalid},
title = {Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphoma},
journal = {British Journal of Dermatology},
year = {2023},
volume = {188},
number = {1},
pages = {145--146},
doi = {10.1093/bjd/ljac012}
}
EUVIMED